A history of CAD (OR 3.68, 95% CI 1.30–10.45, p =0.014), multiple inotrope use (OR 24.99, 95% CI 5.34–116.81, p < 0.001), LVEF <40% (OR 0.20, 95% CI 0.07–0.55, p = 0.002), low hemoglobin (OR 0.83, 95% CI 0.69–1.00, p = 0.053), albumin infusion (OR 4.74, 95% CI 1.49–15.14, p =0.009), CPR attempt (OR 2.21, 95% CI 1.23–3.97, p = 0.008), and RRT (OR 3.00, 95% CI 1.11–8.12, p = 0.031) remain associated with an increased risk for in-hospital mortality and a risk-prediction nomogram, the CSP (Cardiogenic Shock Prognosis) score, was developed accordingly (Figure 2). This evidence concerns the gene ALB and coronary artery disorder.